geraniol and Alloxan Diabetes

geraniol has been researched along with Alloxan Diabetes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
El Azab, EF; Mostafa, HS1
Arvindekar, AU; Ghadyale, VA; Haldavnekar, VS; Kamble, SP; Patil, RS1
Prasad, SN1
El-Bassossy, HM; Elberry, AA; Ghareib, SA1

Other Studies

4 other study(ies) available for geraniol and Alloxan Diabetes

ArticleYear
Geraniol ameliorates the progression of high fat-diet/streptozotocin-induced type 2 diabetes mellitus in rats via regulation of caspase-3, Bcl-2, and Bax expression.
    Journal of food biochemistry, 2022, Volume: 46, Issue:7

    Topics: Acyclic Monoterpenes; alpha-Amylases; alpha-Glucosidases; Animals; bcl-2-Associated X Protein; Caspase 3; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Molecular Docking Simulation; Rats; Rats, Wistar; Streptozocin

2022
Inhibition of GLUT2 transporter by geraniol from Cymbopogon martinii: a novel treatment for diabetes mellitus in streptozotocin-induced diabetic rats.
    The Journal of pharmacy and pharmacology, 2020, Volume: 72, Issue:2

    Topics: Acyclic Monoterpenes; Animals; Cymbopogon; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Glycated Hemoglobin; Hyperglycemia; Male; Rats; Rats, Wistar; Streptozocin

2020
Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations.
    Journal of neuroscience research, 2014, Volume: 92, Issue:9

    Topics: Acyclic Monoterpenes; Administration, Oral; Animals; Body Weight; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Hydrogen Peroxide; Hyperalgesia; Hypoglycemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Oxidoreductases; Psychomotor Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Sciatic Nerve; Terpenes

2014
Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect.
    Journal of diabetes and its complications, 2016, Volume: 30, Issue:6

    Topics: Acyclic Monoterpenes; Animals; Aorta; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Endothelium, Vascular; In Vitro Techniques; Male; Metabolic Syndrome; Rats; Rats, Wistar; Terpenes; Vasodilation; Vasodilator Agents

2016